Concert Genetics
As a technologist and product leader with a range of experience in delivering solutions across several industries, Blake is passionate about connecting the digital infrastructure to enable precision medicine at scale in the U.S. healthcare system. He currently oversees a product portfolio that serves as the system of record for the genetic testing market and offers a platform that digitizes and streamlines test selection, ordering, resulting, coverage, billing and payment.
In addition to his product role, Blake acts as executive lead on several of Concert’s largest health plan customer accounts supporting their adoption of the company’s Genetics Benefit Program, which includes reimbursement policy, coding standards, medical policies, and real-time payment accuracy.
Blake was Concert’s first employee and CTO. In that role, he designed the company’s flexible, cloud-based architecture that today supports real-time integration with providers, laboratories, health plans, and partners across the ecosystem.
Concert Genetics
Genetic testing is the lynchpin of precision medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 75,000 unique genetic testing products on the market, and an average of 10 new products are added each day. This growth confounds the processes through which tests are ordered, resulted, billed and reimbursed. Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans. With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization. Today, stakeholders across the healthcare system turn to Concert Genetics to better understand and navigate the rapid transformation to precision medicine that is underway.